(Q36410862)

14 August 2017

Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia (English)

1 reference

14 August 2017

1 reference

Petter S Woll

2

0 references

Tariq Enver

16

object named as

Tariq Enver

1 reference

14 August 2017

7

Jan Zuna

1 reference

14 August 2017

Christoph Lutz

1

1 reference

14 August 2017

Georgina Hall

3

1 reference

14 August 2017

Anders Castor

4

1 reference

14 August 2017

Helene Dreau

5

1 reference

14 August 2017

Giovanni Cazzaniga

6

1 reference

14 August 2017

Christina Jensen

8

1 reference

14 August 2017

Sally A Clark

9

1 reference

14 August 2017

Andrea Biondi

10

1 reference

14 August 2017

Chris Mitchell

11

1 reference

14 August 2017

Helen Ferry

12

1 reference

14 August 2017

Anna Schuh

13

1 reference

14 August 2017

Veronica Buckle

14

1 reference

14 August 2017

Sten-Eirik W Jacobsen

15

1 reference

14 August 2017

22 October 2012

1 reference

14 August 2017

1 reference

14 August 2017

27

1 reference

14 August 2017

5

1 reference

14 August 2017

1204-1207

1 reference

Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

Minimal residual disease in leukaemia patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

Childhood leukemia: cooperative Berlin-Frankfurt-Münster trials in the Federal Republic of Germany

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

IFNalpha activates dormant haematopoietic stem cells in vivo.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leu

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4693965

Acute lymphoblastic leukaemia

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FLEU.2012.306

Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FLEU.2012.306

Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23086103

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/LEU.2012.306

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

23086103

1 reference